Trials / Completed
CompletedNCT02830789
Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass
Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass in Order to Treat Secondary Hyperparathyroidism: A Clinical Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates whether calcium citrate or calcium carbonate are the optimal supplement to treat secondary hyperparathyroidism following Roux-en-Y gastric bypass operation. Half of the participants will be randomized to receive calcium citrate, while the other half will receive calcium carbonate. The study will be double blinded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Calcium Carbonate | |
| DIETARY_SUPPLEMENT | Calcium Citrate | |
| DIETARY_SUPPLEMENT | Placebo | Tablet manufactured to mimic a calcium carbonate tablet |
| PROCEDURE | Roux-en-Y gastric bypass | Roux-en-Y gastric bypass surgery at least 12 months before study inclusion |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2016-07-13
- Last updated
- 2017-06-26
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02830789. Inclusion in this directory is not an endorsement.